Efficacy of omalizumab (Xolair®) in patients with moderate to severe predominately chronic oral steroid dependent asthma in Taiwan: a retrospective, population-based database cohort study
about
A review of omalizumab for the management of severe asthmaUsing medication utilization information to develop an asthma severity classification model.Biologic agents for severe asthma patients: clinical perspectives and implications."Real-life" Efficacy and Safety Aspects of Four-year Omalizumab Treatment for Asthma.
P2860
Efficacy of omalizumab (Xolair®) in patients with moderate to severe predominately chronic oral steroid dependent asthma in Taiwan: a retrospective, population-based database cohort study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy of omalizumab (Xolair ...... on-based database cohort study
@ast
Efficacy of omalizumab (Xolair ...... on-based database cohort study
@en
type
label
Efficacy of omalizumab (Xolair ...... on-based database cohort study
@ast
Efficacy of omalizumab (Xolair ...... on-based database cohort study
@en
prefLabel
Efficacy of omalizumab (Xolair ...... on-based database cohort study
@ast
Efficacy of omalizumab (Xolair ...... on-based database cohort study
@en
P2093
P2860
P1476
Efficacy of omalizumab (Xolair ...... on-based database cohort study
@en
P2093
Chien-Da Huang
Erin Chang
Han-Pin Kuo
Hao-Cheng Chen
P2860
P2888
P356
10.1186/S12890-015-0156-2
P577
2016-01-08T00:00:00Z
P5875
P6179
1038482735